Melissa Alfinito is currently the Sr. Director of Breast Oncology US Site Management & Monitoring at AstraZeneca. Their career in clinical research began as a Clinical Research Associate in 2000, and they have progressed through various roles at AstraZeneca and PAREXEL, including Oncology Study Leader and Director of US Site Management & Monitoring. Melissa holds a Bachelor of Arts in Psychology from the University of Delaware and is pursuing an MBA in Pharmaceutical Marketing and Management from Saint Joseph's University.
Location
Wilmington, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices